The European Academy of Neurology is looking for an Editor-in-Chief for their future e-Learning platform.

We would like to congratulate the winners of this year’s Investigator Award.

It is with great grief that we announce the loss of our friend and mentor, Professor Ovidiu Alexandru Băjenaru. It would be difficult to write of our beloved colleague in these pages without betraying emotion. A brilliant neurologist, researcher, teacher, husband, father, he leaves behind a profound legacy of perhaps the most influential contemporary figure in Romanian neurology.

In this paper, recently published in Stroke, the authors aimed to compare anterior circulation large vessel occlusion stroke severity between patients with and without COVID-19.

In this paper, recently published in Neurocritical Care, the authors conducted a retrospective cohort study of patients with haemorrhagic stroke (both non-traumatic intracerebral haemorrhage and spontaneous non-aneurysmal subarachnoid haemorrhage) who were hospitalised between March 1, 2020, and May 15, 2020, within a major healthcare system in New York, during the coronavirus pandemic.

In this paper, recently published in Arteriosclerosis, Thrombosis, and Vascular Biology, the authors aimed to determine the prevalence of D-dimer elevation in COVID-19 hospitalisation, trajectory of D-dimer levels during hospitalisation, and association with clinical outcomes.

In this longitudinal study, recently published in the European Journal of Neurology, the authors sought to describe the neurological manifestations of patients with COVID‐19 and gain pathophysiological insights especially with respect to the cytokine release syndrome (CRS).

In this paper, recently published in the European Journal of Neurology, the authors reported four cases of COVID‐19‐related encephalopathy. The diagnosis was made in patients with confirmed COVID‐19 who presented with new‐onset cognitive disturbances, central focal neurological signs or seizures.

In this paper, recently published in the Journal of Neurology, Neurosurgery and Psychiatry, the authors report initial findings of an ongoing community based COVID-19 study in a large UK-wide population of people with multiple sclerosis (pwMS) which coincided with the peak of the COVID-19 outbreak in the UK

Acute cerebrovascular disease, particularly ischaemic stroke, has emerged as a serious complication of COVID-19.

In this paper recently published in Acta Neuropathologica the authors report on neuropathological findings from autopsy for a study cohort of seven COVID-19 patients, all of whom were positive for SARS-CoV-2 by nasopharyngeal swab testing, and compare their observations with those made in a SARS-CoV-2 negative control autopsy cohort comprising individuals with non-septic and systemic inflammatory/septic clinical courses.

The clinical syndrome of COVID-19 infection is complex and implies multiorgan involvement.

In this paper, recently published in the Journal of Neurology, the authors report neurological manifestations in 404 consecutive patients with COVID-19 seen in outpatient clinics and hospitalised between February 20, 2020 and May 4, 2020 at Evergreen Hospital, Kirkland, Washington, USA.

In this paper, recently published in Movement Disorders, the authors explored, through a structured questionnaire, the potential effects of COVID-19 pandemic and lockdown on cognition in Parkinson’s Disease (PD) patients. In particular, they studied 28 PD patients with cognitive disturbance (10 PD with subjective cognitive complaints [SCI]; 10 PD with mild cognitive impairment [MCI] and 8 PD with dementia [PDD]).

In this paper, recently published in the European Journal of Neurology, the authors identified and performed in depth clinical characterisation of a new type of delayed onset movement disorder in five patients who were admitted to the AP-HP intensive care unit (ICU) units for severe SARS-CoV-2 infection.

In this paper, recently published in Annals of Internal Medicine, the authors describe 3 patients without previous neurological or autoimmune disorders who were diagnosed with myasthenia gravis after the onset of coronavirus disease 2019 (COVID-19).